Susan E Siegel - Net Worth and Insider Trading

Susan E Siegel Net Worth

The estimated net worth of Susan E Siegel is at least $1 Million dollars as of 2023-09-23. Susan E Siegel is the Director of Align Technology Inc and owns about 2,971 shares of Align Technology Inc (ALGN) stock worth over $887,022. Susan E Siegel is also the President of Affymetrix Inc and owns about 17,502 shares of Affymetrix Inc (AFFX) stock worth over $245,203. Details can be seen in Susan E Siegel's Latest Holdings Summary section.

Transaction Summary of Susan E Siegel

Susan E Siegel Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Susan E Siegel owns 5 companies in total, including Illumina Inc (ILMN) , Align Technology Inc (ALGN) , and Pacific Biosciences of California Inc (PACB) among others .

Click here to see the complete history of Susan E Siegel’s form 4 insider trades.

Insider Ownership Summary of Susan E Siegel

Ticker	Comapny	Transaction Date	Type of Owner
ILMN	Illumina Inc	2019-02-05	director
ALGN	Align Technology Inc	2020-05-15	director
PACB	Pacific Biosciences of California Inc	2010-10-26	director
AFFX	Affymetrix Inc	2006-01-03	director & President
NVRO	Nevro Corp	2020-12-02	director

Susan E Siegel Latest Holdings Summary

Susan E Siegel currently owns a total of 2 stocks. Among these stocks, Susan E Siegel owns 2,971 shares of Align Technology Inc (ALGN) as of February 12, 2020, with a value of $887,022 and a weighting of 78.34%. Susan E Siegel also owns 17,502 shares of Affymetrix Inc (AFFX) as of January 3, 2006, with a value of $245,203 and a weighting of 21.66%.

Latest Holdings of Susan E Siegel

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
ALGN	Align Technology Inc	2020-02-12	2,971	298.56	887,022
AFFX	Affymetrix Inc	2006-01-03	17,502	14.01	245,203

Holding Weightings of Susan E Siegel

Susan E Siegel Form 4 Trading Tracker

According to the SEC Form 4 filings, Susan E Siegel has made a total of 2 transactions in Align Technology Inc (ALGN) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Align Technology Inc is the sale of 1,400 shares on February 12, 2020, which brought Susan E Siegel around $383,502.

According to the SEC Form 4 filings, Susan E Siegel has made a total of 0 transactions in Affymetrix Inc (AFFX) over the past 5 years. The most-recent trade in Affymetrix Inc is the sale of 5,000 shares on January 3, 2006, which brought Susan E Siegel around $237,150.

Insider Trading History of Susan E Siegel

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Susan E Siegel Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Susan E Siegel Ownership Network

Ownership Network List of Susan E Siegel

No Data

Ownership Network Relation of Susan E Siegel

Susan E Siegel Owned Company Details

What does Illumina Inc do?

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Who are the key executives at Illumina Inc?

Susan E Siegel is the director of Illumina Inc. Other key executives at Illumina Inc include SVP & Chief Technology Officer Steven Barnard , VP & Chief Accounting Officer Scott D Ericksen , and Chief Public Affairs Officer John Edward Frank .

Illumina Inc (ILMN) Insider Trades Summary

Over the past 18 months, Susan E Siegel made no insider transaction in Illumina Inc (ILMN). Other recent insider transactions involving Illumina Inc (ILMN) include a net sale of 9,250 shares made by Susan H Tousi , a net sale of 5,684 shares made by Aimee L Hoyt , and a net sale of 6,298 shares made by Alexander Aravanis .

In summary, during the past 3 months, insiders sold 1,000 shares of Illumina Inc (ILMN) in total and bought 0 shares, with a net sale of 1,000 shares. During the past 18 months, 23,956 shares of Illumina Inc (ILMN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 23,956 shares.

Illumina Inc (ILMN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Illumina Inc Insider Transactions

No Available Data

What does Align Technology Inc do?

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the FDA in 1998, and it has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans and iTero scans make up over half of these scans.

Who are the key executives at Align Technology Inc?

Susan E Siegel is the director of Align Technology Inc. Other key executives at Align Technology Inc include SVP & Chief Legal & Regulatory Julie Ann Coletti , SVP & Chief Marketing Officer Pudipeddi Vamsi Mohan Raj , and SVP & Mng Dir EMEA Markus Christof Sebastian .

Align Technology Inc (ALGN) Insider Trades Summary

Over the past 18 months, Susan E Siegel made no insider transaction in Align Technology Inc (ALGN). Other recent insider transactions involving Align Technology Inc (ALGN) include a net purchase of 20,228 shares made by Joseph M Hogan , a net purchase of 7,000 shares made by Kevin J Dallas , and a net purchase of 1,500 shares made by Anne Myong .

In summary, during the past 3 months, insiders sold 0 shares of Align Technology Inc (ALGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Align Technology Inc (ALGN) were sold and 31,365 shares were bought by its insiders, resulting in a net purchase of 31,365 shares.

Align Technology Inc (ALGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Align Technology Inc Insider Transactions

No Available Data

What does Pacific Biosciences of California Inc do?

Pacific Biosciences of California Inc is a biotechnology company focused on the design, development, and commercialization of tools for biological research. The company develops sequencing systems to assist in resolving genetically complex problems. Its sequencing systems provide access to a wide range of applications and are designed for expandable improvements to performance capability. The majority of the company's revenue is derived from North America, followed by Asia and Europe.

Who are the key executives at Pacific Biosciences of California Inc?

Susan E Siegel is the director of Pacific Biosciences of California Inc. Other key executives at Pacific Biosciences of California Inc include See Remarks Jeff Eidel , Chief Accounting Officer Michele Farmer , and Chief Operating Officer Oene Mark Van .

Pacific Biosciences of California Inc (PACB) Insider Trades Summary

Over the past 18 months, Susan E Siegel made no insider transaction in Pacific Biosciences of California Inc (PACB). Other recent insider transactions involving Pacific Biosciences of California Inc (PACB) include a net sale of 268,450 shares made by Christian O Henry , a net sale of 59,092 shares made by Oene Mark Van , and a net sale of 18,920 shares made by Susan G. Kim .

In summary, during the past 3 months, insiders sold 168,882 shares of Pacific Biosciences of California Inc (PACB) in total and bought 0 shares, with a net sale of 168,882 shares. During the past 18 months, 391,830 shares of Pacific Biosciences of California Inc (PACB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 391,830 shares.

Pacific Biosciences of California Inc (PACB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Pacific Biosciences of California Inc Insider Transactions

No Available Data

What does Affymetrix Inc do?

Affymetrix Inc was incorporated in California in 1992 and reincorporated in Delaware in 1998. The Company is a provider of life science tools and molecular diagnostic products that enable parallel analysis of biological systems at the gene, protein and cell level. It sells its products to genomic research centers, academic institutions, government and private laboratories, as well as pharmaceutical, diagnostic and biotechnology companies. The Companys operations consist of two reportable segments, Affymetrix Core and eBioscience. Affymetrix Core is divided into three business units with each business unit having its own research, development and marketing groups to better serve customers and respond quickly to the market needs. The three business units that form Affymetrix Core are; Expression, Genetic Analysis and Clinical Applications, and Life Science Reagents. Expression: This business unit develops and markets the Company's GeneChip gene expression products and services, and the QuantiGene line of low-to-mid-plex RNA measurement products; Genetic Analysis and Clinical Applications. This business unit develops and markets the Company's genotyping, such as the Axiom product line and clinical research applications, such as the CytoScan cytogenetics; Life Science Reagents; This business unit develops and sells reagents, enzymes, purification kits and biochemicals used by life science researchers. eBioscience; This reportable segment specializes in the development, manufacturing, marketing and distribution of research tools in the areas of flow cytometry, immunoassays, microscopic imaging and other protein-based analyses. The Company markets and distributes its products directly to customers in North America, Japan and major European markets. The Company is facing competition as existing companies develop new or improved products, and as companies enter the market with new technologies, such as next-generation sequencing. In the highly multiplexed genotyping and gene expression markets, existing competitive technologies include DNA sequencing, which the Company does not offer and is offered by companies such as Illumina, Inc., Life Technologies Corporation and Pacific Biosciences of California, Inc. The Companys operations are subject to complex and stringent environmental, health, safety and other governmental laws and regulations.

Who are the key executives at Affymetrix Inc?

Susan E Siegel is the director & President of Affymetrix Inc. Other key executives at Affymetrix Inc include EVP & Chief Operating Officer Andrew J. Last , director & President and CEO Frank Witney , and EVP & Chief Financial Officer Gavin Wood .

Affymetrix Inc (AFFX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Affymetrix Inc (AFFX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Affymetrix Inc (AFFX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Affymetrix Inc (AFFX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Affymetrix Inc Insider Transactions

No Available Data

What does Nevro Corp do?

Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.

Who are the key executives at Nevro Corp?

Susan E Siegel is the director of Nevro Corp. Other key executives at Nevro Corp include Chief Commercial Officer Greg Siller , President & CEO Kevin R Thornal , and Chief Accounting Officer Richard B. Carter .

Nevro Corp (NVRO) Insider Trades Summary

Over the past 18 months, Susan E Siegel made no insider transaction in Nevro Corp (NVRO). Other recent insider transactions involving Nevro Corp (NVRO) include a net purchase of 7,500 shares made by Shawn Mccormick , and a net purchase of 2,250 shares made by Kashif Rashid .

In summary, during the past 3 months, insiders sold 0 shares of Nevro Corp (NVRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nevro Corp (NVRO) were sold and 9,750 shares were bought by its insiders, resulting in a net purchase of 9,750 shares.

Nevro Corp (NVRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Nevro Corp Insider Transactions

No Available Data

Susan E Siegel Mailing Address

Above is the net worth, insider trading, and ownership report for Susan E Siegel. You might contact Susan E Siegel via mailing address: 3000 Sand Hill Road, Bldg 3 Ste 290, Menlo Park Ca 94025.

Discussions on Susan E Siegel

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.